Occentis SAS is a drug discovery and development company specialising in mental health, whose revolutionary approach is based on more than two decades of extensive research carried out at the renowned Centre national de la recherche scientifique (CNRS) under the direction of Professor Marcel Hibert, a leading figure in medicinal chemistry.

Its mission is to revolutionise the treatment landscape for neuropsychiatric and neurobehavioural diseases, addressing significant unmet needs in therapeutic areas such as autism, alcohol and opioid dependence, pain and other illnesses. In collaboration with the CNRS and Professor HIBERT, Occentis aims to address critical unmet needs in mental health.

Occentis is the result of a collaboration between Conectus and Neurentis.